Project NEUWalk Closer to Clinical Trials

A new lab at the CHUV will extend this technology to human patients as early as next summer using an innovative Gait Platform, bringing the European Project NEUWalk closer to clinical trials. The EPFL scientists discovered how to control in real-time how the rat moves forward and how high it lifts its limbs. A new lab at the CHUV will extend this technology to human patients as early as next summer using an innovative Gait Platform which was built with the support of the Valais canton, bringing the European Project NEUWalk closer to clinical trials. Building on earlier work in rats, this new breakthrough is part of a more general therapy that could one day be implemented in rehabilitation programs for people with spinal cord injury, currently being developed in a European project called NEUWalk. Clinical trials could start as early as next summer using the new Gait Platform, built with the support of the Valais canton and now assembled at the CHUV (Lausanne University Hospital). Read more at this link:

Closed-loop neuromodulation of spinal sensorimotor circuits controls refined locomotion after complete spinal cord injury

This entry was posted in Chronic Spinal Cord Injury Research, Rehabilitation, Spinal Research and tagged , , , . Bookmark the permalink.